Key facts
- This page summarizes Jeff Goater's Form 4 filing for VACCINEX, INC. (VCNX).
- 1 reported transaction and 5 derivative rows are listed below.
- Accepted by SEC: 12 May 2021, 16:27.
Jeff Goater - 11 May 2021 Form 4 Insider Report for VACCINEX, INC. (VCNX)
- Reporting relationship
- Director
- Issuer ticker
- VCNX
- Reported as of
- 11 May 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 12 May 2021, 16:27:14 UTC
- Next SEC filing
- 11 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Scott E. Royer, Attorney-in-Fact for Jeff Goater
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jeff Goater filed Form 4 for VACCINEX, INC. (VCNX) on 12 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VCNX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 300
- Date
- 11 May 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VCNX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +28,586
- Change %
- Price
- $0.000000
- Shares after
- 28,586
- Date
- 11 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,586
- Exercise price
- $2.15
- Footnotes
- F4
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,000
- Date
- 11 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,000
- Exercise price
- $14.90
- Footnotes
- F1
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,239
- Date
- 11 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,239
- Exercise price
- $13.60
- Footnotes
- F1
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,718
- Date
- 11 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,718
- Exercise price
- $7.78
- Footnotes
- F2
VCNX
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,679
- Date
- 11 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,679
- Exercise price
- $3.95
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Exercisable in full as of the date of this report.
Footnote F2
This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
Footnote F3
This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
Footnote F4
This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.